115 related articles for article (PubMed ID: 30359859)
1. 3D-QSAR studies of D
Ma J; Zhang H; Zhang X; Lei M
J Mol Graph Model; 2019 Jan; 86():132-141. PubMed ID: 30359859
[TBL] [Abstract][Full Text] [Related]
2. Molecular docking, dynamics simulations and 3D-QSAR modeling of arylpiperazine derivatives of 3,5-dioxo-(2H,4H)-1,2,4-triazine as 5-HT
Sherin DR; Geethu CK; Prabhakaran J; Mann JJ; Dileep Kumar JS; Manojkumar TK
Comput Biol Chem; 2019 Feb; 78():108-115. PubMed ID: 30502727
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and evaluation of benzo[a]thieno[3,2-g]quinolizines as novel l-SPD derivatives possessing dopamine D1, D2 and serotonin 5-HT1A multiple action profiles.
Li Z; Huang J; Sun H; Zhou S; Guo L; Zhou Y; Zhen X; Liu H
Bioorg Med Chem; 2014 Nov; 22(21):5838-46. PubMed ID: 25308766
[TBL] [Abstract][Full Text] [Related]
4. Design of novel dopamine D
Zhang C; Li Q; Meng L; Ren Y
J Biomol Struct Dyn; 2020 Feb; 38(3):860-885. PubMed ID: 30916624
[TBL] [Abstract][Full Text] [Related]
5. Higher-Affinity Agonists of 5-HT1AR Discovered through Tuning the Binding-Site Flexibility.
Lian P; Li L; Geng C; Zhen X; Fu W
J Chem Inf Model; 2015 Aug; 55(8):1616-27. PubMed ID: 26131601
[TBL] [Abstract][Full Text] [Related]
6. Combined serotonin (5-HT)1A agonism, 5-HT(2A) and dopamine D₂ receptor antagonism reproduces atypical antipsychotic drug effects on phencyclidine-impaired novel object recognition in rats.
Oyamada Y; Horiguchi M; Rajagopal L; Miyauchi M; Meltzer HY
Behav Brain Res; 2015 May; 285():165-75. PubMed ID: 25448429
[TBL] [Abstract][Full Text] [Related]
7. Conformational analysis and geometry optimization of buspirone-A 5-HT1A receptor agonist.
Ikram H; Azhar M; Jameel M; Bano K
Pak J Pharm Sci; 2014 Sep; 27(5 Spec no):1515-22. PubMed ID: 25176246
[TBL] [Abstract][Full Text] [Related]
8. Molecular modeling of the 3D structure of 5-HT(1A)R: discovery of novel 5-HT(1A)R agonists via dynamic pharmacophore-based virtual screening.
Xu L; Zhou S; Yu K; Gao B; Jiang H; Zhen X; Fu W
J Chem Inf Model; 2013 Dec; 53(12):3202-11. PubMed ID: 24245825
[TBL] [Abstract][Full Text] [Related]
9. Discovery of Novel Indolealkylpiperazine Derivatives as Potent 5-HT
Zhu C; Li X; Peng W; Fu W
Molecules; 2020 Nov; 25(21):. PubMed ID: 33139658
[TBL] [Abstract][Full Text] [Related]
10. Homology modeling of the human 5-HT1A, 5-HT 2A, D1, and D2 receptors: model refinement with molecular dynamics simulations and docking evaluation.
Yap BK; Buckle MJ; Doughty SW
J Mol Model; 2012 Aug; 18(8):3639-55. PubMed ID: 22354276
[TBL] [Abstract][Full Text] [Related]
11. Asymmetric total synthesis and identification of tetrahydroprotoberberine derivatives as new antipsychotic agents possessing a dopamine D(1), D(2) and serotonin 5-HT(1A) multi-action profile.
Sun H; Zhu L; Yang H; Qian W; Guo L; Zhou S; Gao B; Li Z; Zhou Y; Jiang H; Chen K; Zhen X; Liu H
Bioorg Med Chem; 2013 Feb; 21(4):856-68. PubMed ID: 23332346
[TBL] [Abstract][Full Text] [Related]
12. Computational Study and Modified Design of Selective Dopamine D3 Receptor Agonists.
Duan X; Zhang X; Xu B; Wang F; Lei M
Chem Biol Drug Des; 2016 Jul; 88(1):142-54. PubMed ID: 26851125
[TBL] [Abstract][Full Text] [Related]
13. Binding modes of chain arylpiperazines to 5-HT1a, 5-HT2a and 5-HT7 receptors.
Bielenica A; Kozioł AE; Struga M
Mini Rev Med Chem; 2013 Aug; 13(10):1516-39. PubMed ID: 24568298
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, biological evaluation, and docking studies of tetrahydrofuran- cyclopentanone- and cyclopentanol-based ligands acting at adrenergic α₁- and serotonine 5-HT1A receptors.
Prandi A; Franchini S; Manasieva LI; Fossa P; Cichero E; Marucci G; Buccioni M; Cilia A; Pirona L; Brasili L
J Med Chem; 2012 Jan; 55(1):23-36. PubMed ID: 22145629
[TBL] [Abstract][Full Text] [Related]
15. 1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.
Franchini S; Prandi A; Baraldi A; Sorbi C; Tait A; Buccioni M; Marucci G; Cilia A; Pirona L; Fossa P; Cichero E; Brasili L
Eur J Med Chem; 2010 Sep; 45(9):3740-51. PubMed ID: 20605276
[TBL] [Abstract][Full Text] [Related]
16. In silico Analysis and Experimental Validation of Lignan Extracts from Kadsura longipedunculata for Potential 5-HT1AR Agonists.
Zheng Y; Wu J; Feng X; Jia Y; Huang J; Hao Z; Zhao S; Wang J
PLoS One; 2015; 10(6):e0130055. PubMed ID: 26076134
[TBL] [Abstract][Full Text] [Related]
17. Molecular docking, 3D-QSAR and structural optimization on imidazo-pyridine derivatives dually targeting AT1 and PPARg.
Zhang J; Hao QQ; Liu X; Jing Z; Jia WQ; Wang SQ; Xu WR; Cheng XC; Wang RL
Oncotarget; 2017 Apr; 8(15):25612-25627. PubMed ID: 28445965
[TBL] [Abstract][Full Text] [Related]
18. Serotonin (5-HT)1A receptor agonism and 5-HT7 receptor antagonism ameliorate the subchronic phencyclidine-induced deficit in executive functioning in mice.
Rajagopal L; Massey BW; Michael E; Meltzer HY
Psychopharmacology (Berl); 2016 Feb; 233(4):649-60. PubMed ID: 26558619
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of arylpiperazines derivatives of 3,5-dioxo-(2H,4H)-1,2,4-triazine as 5-HT1AR ligands.
Kumar JSD; Majo VJ; Prabhakaran J; Mann JJ
Bioorg Med Chem Lett; 2014 Oct; 24(19):4759-4762. PubMed ID: 25182564
[TBL] [Abstract][Full Text] [Related]
20. Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT 2A receptors: functional receptor-binding and in vivo electrophysiological studies.
Stark AD; Jordan S; Allers KA; Bertekap RL; Chen R; Mistry Kannan T; Molski TF; Yocca FD; Sharp T; Kikuchi T; Burris KD
Psychopharmacology (Berl); 2007 Feb; 190(3):373-82. PubMed ID: 17242925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
